Related Experiment Video
Updated: Jul 3, 2026

Transcranial Direct Current Stimulation for Online Gamers
Published on: November 9, 2019
Effects of transcranial direct current stimulation on Nicotine Use Disorder: A systematic review and meta-analysis
Cindy P S Niap1, Na Ooi1, Hui En Ang1
1Jeffrey Cheah School of Medicine and Health Sciences, Clinical School Johor Bahru, Monash University Malaysia, Johor Bahru, 80100, Johor, Malaysia.
Introduction:
Transcranial direct current stimulation (tDCS) is a viable non-invasive approach to counter nicotine addiction. This systematic review and meta-analysis aim to investigate the effects of tDCS on smoking behaviours in Nicotine Use Disorder (NUD) and explore neuroimaging findings related to these effects.
Methods:
Systematic review following PRISMA guidelines shortlisted 21 studies. Primary outcome measures were effects of tDCS vs sham on smoking (i) craving, (ii) consumption and (iii)accompanying neuroimaging results. Random effects meta-analysis was conducted on 6 comparisons for smoking craving and 13 comparisons for smoking consumption. Anodal and cathodal stimulations were evaluated as moderator variables via meta-regression. Five studies with neuroimaging data supporting tDCS effects on smoking behaviours were reviewed. GRADE methodology was applied to assess evidence quality.
Results:
Compared to sham, tDCS produced a small reduction in nicotine craving (Hedges' g = -0.26, 95%CI (-0.51, -0.01)) with moderate certainty, and moderate reduction in consumption (Hedges' g = -0.48, 95%CI [-0.79, -0.17],) with low certainty; all within the first day post-stimulation. Moderator analyses did not identify specific electrode placements that effectively reduce nicotine craving or intake. Five studies evaluated tDCS effects on smoking behaviours with neuroimaging support namely fMRI, fNIRS and EEG, providing additional insights to neurobiology of nicotine addiction.
Conclusion:
Current evidence indicates that tDCS may be associated with changes in craving and consumption in NUD. Further research is required to establish efficacy, identify key moderators, and integrate neuroimaging to explore tDCS effects in smoking cessation.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
